Sodium Bicarbonate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Mar 1, 2017. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-5555-02
- Dosage Form
- Injection
- Presentation
- Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)
- Initial Posting
- Mar 1, 2017
Reason
Demand increase for the drug